A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors

A. Craig Lockhart, Emiliano Calvo, Anthony W. Tolcher, Eric K. Rowinsky, Gareth Shackleton, J. Gilmour Morrison, Rezvan Rafi, Wendy VerMeulen, Mace L. Rothenberg

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences